García G, Brazís P, Majó N, Ferrer L, de Mora F, Puigdemont A
Departament de Farmacologia i Terapèutica Universitat Autònoma de Barcelona, Spain.
Vet Immunol Immunopathol. 1998 Apr 30;62(4):323-37. doi: 10.1016/s0165-2427(97)00166-9.
The dog mastocytoma BR cell line provides us with a permanent source of canine mast cells, allowing a characterization of secretory mediators that exert important effects in canine allergic and nonallergic diseases and in physiological processes. We studied the ultrastructural characteristics and histamine releasing activity after immunological and non-immunological stimuli of the dog mastocytoma BR cell line, and compared the cell line to normal skin mast cells enzymatically isolated from healthy dogs. The histamine content of BR cells was 0.04 +/- 0.002 pg/cell, approximately 100-fold less than that found in canine skin mast cells. Non-immunologic stimuli induced similar concentration-dependent histamine release from skin mast cells and BR cells: 29.3 +/- 0.9% vs. 12.7 +/- 0.7% (calcium ionophore A23187), 23.3 +/- 0.7% vs. 18.8 +/- 0.7% (substance P) and 12.5 +/- 0.3% vs. 12.1 +/- 0.9% (compound 48/80), respectively. Immunologic stimulation, however, was only effective on canine skin mast cells, causing 30.9 +/- 1.7%, 27.7 +/- 0.6% and 12.2 +/- 0.9% histamine release in response to anti-canine IgE, concanavalin A, and antigen Asc S 1, respectively. The absence of functional IgE receptors in BR cells was confirmed by the lack of response to anti-IgE and antigen Asc S 1 following passive sensitization with dog atopic serum and dog antigen sensitized serum. We conclude that BR cells are able to release histamine after non-immunologic stimulation in a similar manner to canine skin mast cells, but that there are morphological and functional differences possibly due to different states of maturity or differentiation. For this reason the study of the highly homogeneous BR cells could offer insights into dog mast cell biology in contexts where freshly isolated cells cannot be used because of low purity and recovery.
犬肥大细胞瘤BR细胞系为我们提供了犬肥大细胞的永久来源,有助于对在犬类过敏性和非过敏性疾病以及生理过程中发挥重要作用的分泌介质进行表征。我们研究了犬肥大细胞瘤BR细胞系在免疫和非免疫刺激后的超微结构特征和组胺释放活性,并将该细胞系与从健康犬身上酶法分离的正常皮肤肥大细胞进行了比较。BR细胞的组胺含量为0.04±0.002 pg/细胞,约为犬皮肤肥大细胞中组胺含量的100分之一。非免疫刺激诱导皮肤肥大细胞和BR细胞释放组胺的浓度依赖性相似:分别为29.3±0.9%对12.7±0.7%(钙离子载体A23187)、23.3±0.7%对18.8±0.7%(P物质)和12.5±0.3%对12.1±0.9%(化合物48/80)。然而,免疫刺激仅对犬皮肤肥大细胞有效,分别对抗犬IgE、伴刀豆球蛋白A和抗原Asc S 1产生30.9±1.7%、27.7±0.6%和12.2±0.9%的组胺释放。在用犬特应性血清和犬抗原致敏血清进行被动致敏后,BR细胞对抗IgE和抗原Asc S 1无反应,证实了BR细胞中缺乏功能性IgE受体。我们得出结论,BR细胞在非免疫刺激后能够以与犬皮肤肥大细胞相似的方式释放组胺,但存在形态和功能上的差异,这可能是由于成熟或分化状态不同所致。因此,在由于纯度和回收率低而无法使用新鲜分离细胞的情况下,对高度同质的BR细胞进行研究可能有助于深入了解犬肥大细胞生物学。